Pub Date : 2024-05-01DOI: 10.1016/j.otoeng.2023.10.004
Carmen Fernández-Cedrón , Paula Sánchez-Fernández , Maite Guntín-García , Isabel Sandoval-Menéndez , Justo Gómez-Martínez , Jose Luis Llorente-Pendás , Faustino Núñez-Batalla
Introduction
The enlarged vestibular aqueduct (EVA) is the most frequent malformation of the inner ear associated with sensorineural hearing loss (5–15%). It exists when the diameter in imaging tests is greater than 1.5 mm at its midpoint. The association between hearing loss and EVA has been described in a syndromic and non-syndromic manner. It can appear as a familial or isolated form and the audiological profile is highly variable. The gene responsible for sensorineural hearing loss associated with EVA is located in the same region described for Pendred syndrome, where the SCL26A4 gene is located.
Objective
To describe a series of children diagnosed with EVA in order to study their clinical and audiological characteristics, as well as the associated genetic and vestibular alterations.
Method
Retrospective study of data collection of children diagnosed with EVA, from April 2014 to February 2023.
Results
Of the 17 cases, 12 were male and 5 were female. 5 of them were unilateral and 12 bilateral. In 5 cases, a cranial traumatism triggered the hearing loss. Genetic alterations were detected in 3 cases: 2 mutations in the SCL26A4 gene and 1 mutation in the MCT1 gene. 13 patients (76.5%) were rehabilitated with hearing aids and 9 of them required cochlear implantation.
Discussion
The clinical importance of AVD lies in the fact that it is a frequent finding in the context of postneonatal hearing loss. It is convenient to have a high suspicion to diagnose it with imaging tests, to monitor its evolution, and to rehabilitate early.
引言前庭导水管扩大（EVA）是与感音神经性听力损失相关的最常见的内耳畸形（5%-15%）。当造影检查发现其中点直径大于 1.5 毫米时，即为 EVA。听力损失与 EVA 之间的关系有综合征和非综合征之分。听力损失可表现为家族性或孤立性，听力学特征变化很大。与 EVA 相关的感音神经性听力损失的致病基因位于与 Pendred 综合征相同的区域，即 SCL26A4 基因所在区域：描述一系列被诊断为 EVA 的儿童，以研究他们的临床和听力特征，以及相关的遗传和前庭改变：方法：对2014年4月至2023年2月期间确诊为EVA的儿童进行数据收集的回顾性研究：结果：17 例病例中，12 例为男性，5 例为女性。其中 5 例为单侧，12 例为双侧。在 5 例病例中，颅脑创伤引发了听力损失。3例患者的基因发生了改变：2例是SCL26A4基因突变，1例是MCT1基因突变。13名患者（76.5%）使用助听器进行了康复治疗，其中9人需要植入人工耳蜗：讨论：AVD 的临床重要性在于它是新生儿出生后听力损失的常见病。高度怀疑并通过影像学检查进行诊断、监测其发展并及早进行康复治疗是非常方便的。
{"title":"Enlarged vestibular aqueduct as a cause of postneonatal deafness","authors":"Carmen Fernández-Cedrón , Paula Sánchez-Fernández , Maite Guntín-García , Isabel Sandoval-Menéndez , Justo Gómez-Martínez , Jose Luis Llorente-Pendás , Faustino Núñez-Batalla","doi":"10.1016/j.otoeng.2023.10.004","DOIUrl":"10.1016/j.otoeng.2023.10.004","url":null,"abstract":"<div><h3>Introduction</h3><p>The enlarged vestibular aqueduct (EVA) is the most frequent malformation of the inner ear associated with sensorineural hearing loss (5–15%). It exists when the diameter in imaging tests is greater than 1.5 mm at its midpoint. The association between hearing loss and EVA has been described in a syndromic and non-syndromic manner. It can appear as a familial or isolated form and the audiological profile is highly variable. The gene responsible for sensorineural hearing loss associated with EVA is located in the same region described for Pendred syndrome, where the SCL26A4 gene is located.</p></div><div><h3>Objective</h3><p>To describe a series of children diagnosed with EVA in order to study their clinical and audiological characteristics, as well as the associated genetic and vestibular alterations.</p></div><div><h3>Method</h3><p>Retrospective study of data collection of children diagnosed with EVA, from April 2014 to February 2023.</p></div><div><h3>Results</h3><p>Of the 17 cases, 12 were male and 5 were female. 5 of them were unilateral and 12 bilateral. In 5 cases, a cranial traumatism triggered the hearing loss. Genetic alterations were detected in 3 cases: 2 mutations in the SCL26A4 gene and 1 mutation in the MCT1 gene. 13 patients (76.5%) were rehabilitated with hearing aids and 9 of them required cochlear implantation.</p></div><div><h3>Discussion</h3><p>The clinical importance of AVD lies in the fact that it is a frequent finding in the context of postneonatal hearing loss. It is convenient to have a high suspicion to diagnose it with imaging tests, to monitor its evolution, and to rehabilitate early.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 3","pages":"Pages 177-184"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139718111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.otoeng.2023.07.001
Rosa-Delia Ramírez-Ruiz , Mariam Quintillá , Marta Sandoval , Lucía León , Jose Miguel Costa , Miquel Quer
Purpose
This study evaluates expert opinion on laryngeal electromyography (LEMG).
Methods
A cross-sectional design was used to conduct an online survey of LEMG experts in 2021. They were questioned about the number LEMG performed annually, type of electrodes used, sector worked in, pain during the test, placement of the needle electrodes, interpretation of electrical muscle parameters, diagnosis of neuromuscular injury, prognostic sensitivity in vocal fold paralysis (VFP), laryngeal dystonia, tremor and synkinesis and quantifying LEMG.
Results
Thirty-seven professionals answered (23 Spanish and 14 from other countries), with a response rate of 21.56%. All physicians used LEMG. 91.9% had one- or two-years’ experience and 56.8% performed 10–40 LEMG per year. 70.3% were otolaryngologists and 27%, neurologists. In 89.1% of cases, a team of electrodiagnostic physician and otolaryngologist performed LEMG. 91.3% of Spanish respondents worked in Public Health, 7.14% of other nationalities; 37.8% in a university department. Bipolar concentric needles electrodes were used by 45.9% and monopolar concentric by 40.5%. 57% professionals considered good patients’ tolerance to the test. LEMG sensitivity was regarded as strong, median and interquartile range were 80.0 [60.0;90.0] to diagnose peripheral nerve injuries, less for other levels of lesions, and strong to evaluate prognosis, 70.0 [50.0;80.0]. Respondents believe locate the thyroarytenoid and the cricothyroid muscles with the needle, 80.0 [70.0;90.0], as opposed to 20.0 [0.00;60.0] the posterior cricoarytenoid. The interpretation of the electrical parts of the LEMG was strong, 80.0 [60.0;90.0]. LEMG identify movements disorders, 60.0 [20.0;80.0], and synkinesis, 70.0 [30.0;80.0]. The professionals prefer quantitative LEMG, 90.0 [60.0;90.0].
Conclusions
The experts surveyed consider LEMG that is well tolerated by patients. The insertional and spontaneous activity, recruitment and waveform morphology can be assessed easily. LEMG is mainly useful in the study of peripheral nerve injuries, and its value in VFP prognosis is considered strong.
{"title":"Current opinion on laryngeal electromyography","authors":"Rosa-Delia Ramírez-Ruiz , Mariam Quintillá , Marta Sandoval , Lucía León , Jose Miguel Costa , Miquel Quer","doi":"10.1016/j.otoeng.2023.07.001","DOIUrl":"10.1016/j.otoeng.2023.07.001","url":null,"abstract":"<div><h3>Purpose</h3><p>This study evaluates expert opinion on laryngeal electromyography (LEMG).</p></div><div><h3>Methods</h3><p><span>A cross-sectional design was used to conduct an online survey of LEMG experts in 2021. They were questioned about the number LEMG performed annually, type of electrodes used, sector worked in, pain during the test, placement of the needle electrodes, interpretation of electrical muscle parameters, diagnosis of neuromuscular injury, prognostic sensitivity in </span>vocal fold<span> paralysis (VFP), laryngeal dystonia<span>, tremor and synkinesis and quantifying LEMG.</span></span></p></div><div><h3>Results</h3><p><span>Thirty-seven professionals answered (23 Spanish and 14 from other countries), with a response rate of 21.56%. All physicians used LEMG. 91.9% had one- or two-years’ experience and 56.8% performed 10–40 LEMG per year. 70.3% were otolaryngologists and 27%, neurologists. In 89.1% of cases, a team of electrodiagnostic physician and otolaryngologist performed LEMG. 91.3% of Spanish respondents worked in </span>Public Health<span>, 7.14% of other nationalities; 37.8% in a university department. Bipolar concentric needles electrodes were used by 45.9% and monopolar concentric by 40.5%. 57% professionals considered good patients’ tolerance to the test. LEMG sensitivity was regarded as strong, median and interquartile range were 80.0 [60.0;90.0] to diagnose peripheral nerve injuries<span>, less for other levels of lesions, and strong to evaluate prognosis, 70.0 [50.0;80.0]. Respondents believe locate the thyroarytenoid and the cricothyroid muscles with the needle, 80.0 [70.0;90.0], as opposed to 20.0 [0.00;60.0] the posterior cricoarytenoid. The interpretation of the electrical parts of the LEMG was strong, 80.0 [60.0;90.0]. LEMG identify movements disorders, 60.0 [20.0;80.0], and synkinesis, 70.0 [30.0;80.0]. The professionals prefer quantitative LEMG, 90.0 [60.0;90.0].</span></span></p></div><div><h3>Conclusions</h3><p>The experts surveyed consider LEMG that is well tolerated by patients. The insertional and spontaneous activity, recruitment and waveform morphology can be assessed easily. LEMG is mainly useful in the study of peripheral nerve injuries, and its value in VFP prognosis is considered strong.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 3","pages":"Pages 148-154"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.otoeng.2023.07.005
Xavier León , Susana López , María Pérez , Cristina Valero , Anna Holgado , Miquel Quer , Carmen Vega
Introduction
Out of all cutaneous squamous cell carcinomas originating in the head and neck (HNCSCC), 2–4% are associated with parotid or cervical lymph node metastasis. The aim of this study is to analyse the prognostic factors of patients with HNCSCC with lymph node involvement treated surgically. Additionally, we aim to compare the prognostic capacity of the classification of these patients according to the 8th edition of the TNM, and an alternative classification proposed by O'Brien et al.
Patients and methods
Retrospective review of 65 patients with HNCSCC with lymph node metastasis treated surgically during the period 2000–2020.
Results
During the study period we carried out 13 neck dissections and 52 parotidectomies + neck dissection in patients with lymph node metastases from a HNCSCC. The great majority of patients (89.2%) received post-operative radiotherapy. The 5 year disease-specific survival was 69.9%, and the overall survival it was 42.8%. The classification proposed by O'Brien et al., based on the parotid or cervical location of the lymph node metastases, and the size and number of the metastatic lymph nodes, had a better prognostic capacity than the TNM classification.
Conclusions
The surgical treatment of lymph node metastases in patients with HNCSCC achieved a high disease control. The classification based on the location, size and number of lymph node metastases proposed by O'Brien et al had better prognostic capacity than the TNM classification.
{"title":"Results of surgical treatment of lymph node metastases in patients with cutaneous squamous cell carcinoma of the head and neck","authors":"Xavier León , Susana López , María Pérez , Cristina Valero , Anna Holgado , Miquel Quer , Carmen Vega","doi":"10.1016/j.otoeng.2023.07.005","DOIUrl":"10.1016/j.otoeng.2023.07.005","url":null,"abstract":"<div><h3>Introduction</h3><p><span><span>Out of all cutaneous squamous cell carcinomas originating in the head and neck (HNCSCC), 2–4% are associated with parotid or cervical </span>lymph node metastasis. The aim of this study is to analyse the </span>prognostic factors of patients with HNCSCC with lymph node involvement treated surgically. Additionally, we aim to compare the prognostic capacity of the classification of these patients according to the 8th edition of the TNM, and an alternative classification proposed by O'Brien et al.</p></div><div><h3>Patients and methods</h3><p>Retrospective review of 65 patients with HNCSCC with lymph node metastasis treated surgically during the period 2000–2020.</p></div><div><h3>Results</h3><p><span>During the study period we carried out 13 neck dissections<span> and 52 parotidectomies + neck dissection </span></span>in patients with lymph node metastases from a HNCSCC. The great majority of patients (89.2%) received post-operative radiotherapy. The 5 year disease-specific survival was 69.9%, and the overall survival it was 42.8%. The classification proposed by O'Brien et al., based on the parotid or cervical location of the lymph node metastases, and the size and number of the metastatic lymph nodes, had a better prognostic capacity than the TNM classification.</p></div><div><h3>Conclusions</h3><p>The surgical treatment of lymph node metastases in patients with HNCSCC achieved a high disease control. The classification based on the location, size and number of lymph node metastases proposed by O'Brien et al had better prognostic capacity than the TNM classification.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 3","pages":"Pages 169-176"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139473177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.otoeng.2023.10.007
Sara Reda del Barrio , Joaquín de Vergas Gutiérrez , Juan Francisco Quesada-Espinosa , María Teresa Sánchez-Calvín , Irene Gómez-Manjón , Olalla Sierra-Tomillo , Alexandra Juárez-Rufián , Alfredo García Fernández
Introduction
The contribution of genetic causes to sensorineural hearing loss (SNHL) in adults is less clear than in children, and genetic diagnosis is still not standardized in adults. In this study we present the genetic results obtained in a cohort of adult patients with SNHL.
Materials and methods
We included 63 adults with SNHL that received genetic testing between 2019 and 2022. Whole exome sequencing was performed and variants in genes related to hearing loss (virtual panel with 244 genes) were prioritised and analysed.
Results
24% (15/63) of patients were genetically diagnosed: 87% (13/15) of patients had non-syndromic hearing loss and 13% (2/15) had syndromic hearing loss. We identified pathogenic and likely pathogenic variants in 11 different genes.
Conclusions
Our results show that a significant proportion of adults with SNHL have a genetic origin, and that implementation of genetic testing improves diagnostic accuracy and allows personalized management of these patients.
{"title":"Diagnostic yield of genetic testing in adults with sensorineural hearing loss","authors":"Sara Reda del Barrio , Joaquín de Vergas Gutiérrez , Juan Francisco Quesada-Espinosa , María Teresa Sánchez-Calvín , Irene Gómez-Manjón , Olalla Sierra-Tomillo , Alexandra Juárez-Rufián , Alfredo García Fernández","doi":"10.1016/j.otoeng.2023.10.007","DOIUrl":"10.1016/j.otoeng.2023.10.007","url":null,"abstract":"<div><h3>Introduction</h3><p>The contribution of genetic causes to sensorineural hearing loss (SNHL) in adults is less clear than in children, and genetic diagnosis is still not standardized in adults. In this study we present the genetic results obtained in a cohort of adult patients with SNHL.</p></div><div><h3>Materials and methods</h3><p>We included 63 adults with SNHL that received genetic testing between 2019 and 2022. Whole exome sequencing was performed and variants in genes related to hearing loss (virtual panel with 244 genes) were prioritised and analysed.</p></div><div><h3>Results</h3><p>24% (15/63) of patients were genetically diagnosed: 87% (13/15) of patients had non-syndromic hearing loss and 13% (2/15) had syndromic hearing loss. We identified pathogenic and likely pathogenic variants in 11 different genes.</p></div><div><h3>Conclusions</h3><p>Our results show that a significant proportion of adults with SNHL have a genetic origin, and that implementation of genetic testing improves diagnostic accuracy and allows personalized management of these patients.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 3","pages":"Pages 185-191"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.otoeng.2023.10.009
Ángel Roco-Videla , Valeska Torres-Bustos
{"title":"Regarding the process of adaptation and validation into Spanish of the specific questionnaire on quality of life in patients with tracheostomy (TQOL)","authors":"Ángel Roco-Videla , Valeska Torres-Bustos","doi":"10.1016/j.otoeng.2023.10.009","DOIUrl":"10.1016/j.otoeng.2023.10.009","url":null,"abstract":"","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 3","pages":"Pages 200-201"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140023640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.otoeng.2023.09.005
Tjerk Winus Aukema , Ivo Joachim Kruyt , Myrthe Karianne Sophie Hol
{"title":"Comment on “Skin and soft tissue complications of bone-anchored hearing aids: Introducing a new classification system”","authors":"Tjerk Winus Aukema , Ivo Joachim Kruyt , Myrthe Karianne Sophie Hol","doi":"10.1016/j.otoeng.2023.09.005","DOIUrl":"10.1016/j.otoeng.2023.09.005","url":null,"abstract":"","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 133-134"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136127322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.otoeng.2023.10.005
Luis Lassaletta , Leticia Acle Cervera , Xabier Altuna , Emilio Amilibia Cabeza , Miguel Arístegui Ruiz , Ángel Batuecas Caletrio , Jesús Benítez del Rosario , Rubén Cabanillas Farpón , María Costales Marcos , Pedro Escada , Juan Manuel Espinosa-Sánchez , Roberto García Leal , Javier Gavilán , Justo Gómez Martínez , Rocío González-Aguado , Victor Martinez-Glez , Gloria Guerra Jiménez , Alejandro Harguindey Antolí-Candela , Borja J. Hernández García , Cesar Orús Dotú , José Manuel Morales Puebla
Introduction
Vestibular schwannoma (VS) is the most common tumour of the cerebellopontine angle. The greater accessibility to radiological tests has increased its diagnosis. Taking into account the characteristics of the tumour, the symptoms and the age of the patient, three therapeutic strategies have been proposed: observation, surgery or radiotherapy. Choosing the most appropriate for each patient is a frequent source of controversy.
Material and methods
This paper includes an exhaustive literature review of issues related to VS that can serve as a clinical guide in the management of patients with these lesions. The presentation has been oriented in the form of questions that the clinician usually asks himself and the answers have been written and/or reviewed by a panel of national and international experts consulted by the Otology Commission of the SEORL-CCC.
Results
A list has been compiled containing the 13 most controversial thematic blocks on the management of VS in the form of 50 questions, and answers to all of them have been sought through a systematic literature review (articles published on PubMed and Cochrane Library between 1992 and 2023 related to each thematic area). Thirty-three experts, led by the Otology Committee of SEORL-CCC, have analyzed and discussed all the answers. In Annex 1, 14 additional questions divided into 4 thematic areas can be found.
Conclusions
This clinical practice guideline on the management of VS offers agreed answers to the most common questions that are asked about this tumour. The absence of sufficient prospective studies means that the levels of evidence on the subject are generally medium or low. This fact increases the interest of this type of clinical practice guidelines prepared by experts.
{"title":"Clinical practice guideline on the management of vestibular schwannoma","authors":"Luis Lassaletta , Leticia Acle Cervera , Xabier Altuna , Emilio Amilibia Cabeza , Miguel Arístegui Ruiz , Ángel Batuecas Caletrio , Jesús Benítez del Rosario , Rubén Cabanillas Farpón , María Costales Marcos , Pedro Escada , Juan Manuel Espinosa-Sánchez , Roberto García Leal , Javier Gavilán , Justo Gómez Martínez , Rocío González-Aguado , Victor Martinez-Glez , Gloria Guerra Jiménez , Alejandro Harguindey Antolí-Candela , Borja J. Hernández García , Cesar Orús Dotú , José Manuel Morales Puebla","doi":"10.1016/j.otoeng.2023.10.005","DOIUrl":"10.1016/j.otoeng.2023.10.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Vestibular schwannoma (VS) is the most common tumour of the cerebellopontine angle. The greater accessibility to radiological tests has increased its diagnosis. Taking into account the characteristics of the tumour, the symptoms and the age of the patient, three therapeutic strategies have been proposed: observation, surgery or radiotherapy. Choosing the most appropriate for each patient is a frequent source of controversy.</p></div><div><h3>Material and methods</h3><p>This paper includes an exhaustive literature review of issues related to VS that can serve as a clinical guide in the management of patients with these lesions. The presentation has been oriented in the form of questions that the clinician usually asks himself and the answers have been written and/or reviewed by a panel of national and international experts consulted by the Otology Commission of the SEORL-CCC.</p></div><div><h3>Results</h3><p>A list has been compiled containing the 13 most controversial thematic blocks on the management of VS in the form of 50 questions, and answers to all of them have been sought through a systematic literature review (articles published on PubMed and Cochrane Library between 1992 and 2023 related to each thematic area). Thirty-three experts, led by the Otology Committee of SEORL-CCC, have analyzed and discussed all the answers. In Annex 1, 14 additional questions divided into 4 thematic areas can be found.</p></div><div><h3>Conclusions</h3><p>This clinical practice guideline on the management of VS offers agreed answers to the most common questions that are asked about this tumour. The absence of sufficient prospective studies means that the levels of evidence on the subject are generally medium or low. This fact increases the interest of this type of clinical practice guidelines prepared by experts.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 108-128"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To investigate the role of allergic rhinitis (AR) and non-allergic rhinitis (NAR) on success of type 1 cartilage tympanoplasty.
Methods
This prospective study was conducted on 60 patients who had type 1 cartilage tympanoplasty. The patients were divided into three groups as no-rhinitis (n = 28), NAR (n = 18) and AR (n = 14) groups, based on their symptoms, skin prick tests and/or serum specific IgE levels. AR and NAR groups were treated for their rhinitis symptoms both pre- and postoperatively. The patients were followed up for a minimum of 6 months and compared for graft success rates and audiological outcomes.
Results
Three study groups were similar for age, gender distributions and preoperative air-bone gaps (p = 0.780, p = 0.167 and p = 0.676, respectively). Postoperative graft perforation rate was 0% in no-rhinitis and AR groups while it was 16.7% in NAR group, with a significant difference among three groups (p = 0.034). The comparison of three study groups for change in the postoperative air bone gaps in comparison with preoperative air bone gaps did not yield any statistically significant result (p = 0.729).
Conclusion
Although AR does not result in failure of type 1 cartilage tympanoplasty in patients treated for rhinitis compared to the control group, NAR does. Pre- and postoperative treatment of patients for rhinitis and employment of cartilage graft may be the key factors for success of surgery in patients with AR. Further studies with a larger sample size are needed.
{"title":"The role of allergic and nonallergic rhinitis on success of type 1 cartilage tympanoplasty","authors":"Elif Ersoy Çallıoğlu , Kazım Bozdemir , Şadan Soyyiğit , Saliha Atalay , Bengi Arslan","doi":"10.1016/j.otoeng.2023.10.001","DOIUrl":"10.1016/j.otoeng.2023.10.001","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the role of allergic rhinitis<span> (AR) and non-allergic rhinitis (NAR) on success of type 1 cartilage tympanoplasty.</span></p></div><div><h3>Methods</h3><p>This prospective study was conducted on 60 patients who had type 1 cartilage tympanoplasty. The patients were divided into three groups as no-rhinitis (<em>n</em> = 28), NAR (<em>n</em> = 18) and AR (<em>n</em> = 14) groups, based on their symptoms, skin prick tests and/or serum specific IgE levels. AR and NAR groups were treated for their rhinitis symptoms both pre- and postoperatively. The patients were followed up for a minimum of 6 months and compared for graft success rates and audiological outcomes.</p></div><div><h3>Results</h3><p>Three study groups were similar for age, gender distributions and preoperative air-bone gaps (<em>p</em> = 0.780, <em>p</em> = 0.167 and <em>p</em> = 0.676, respectively). Postoperative graft perforation rate was 0% in no-rhinitis and AR groups while it was 16.7% in NAR group, with a significant difference among three groups (<em>p</em> = 0.034). The comparison of three study groups for change in the postoperative air bone gaps in comparison with preoperative air bone gaps did not yield any statistically significant result (<em>p</em> = 0.729).</p></div><div><h3>Conclusion</h3><p>Although AR does not result in failure of type 1 cartilage tympanoplasty in patients<span> treated for rhinitis compared to the control group, NAR does. Pre- and postoperative treatment of patients for rhinitis and employment of cartilage graft may be the key factors for success of surgery in patients with AR. Further studies with a larger sample size are needed.</span></p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 102-107"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.otoeng.2024.01.001
Encarnación Antúnez-Estudillo , Laura Riera Tur , Andrés Caballero García
Introduction
Pinna infections are usually due to Staphylococcus aureus infection. It is common for the patient to have had an earring in the area of infection. Monkeypox infection has gone from being an endemic infection to a worldwide health emergency.
Case summary
In this article we present five cases of monkeypox earring infection of the pinna and what common features we have seen that differentiate them from Staphylococcus aureus infection.
Discussion
Symptoms of monkeypox include general malaise, fever with uni- or bilateral lymphadenopathy, and then the appearance within one or two days of skin lesions, we want to alert he otolaryngologist and the medical society to the possibility the diagnostic possibility of monkeypox in patients with an auricular perichondritis.
{"title":"Perichondritis and auricular cellulitis related to piercings as first manifestation of monkeypox","authors":"Encarnación Antúnez-Estudillo , Laura Riera Tur , Andrés Caballero García","doi":"10.1016/j.otoeng.2024.01.001","DOIUrl":"10.1016/j.otoeng.2024.01.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Pinna infections are usually due to <em>Staphylococcus aureus</em><span> infection. It is common for the patient to have had an earring in the area of infection. Monkeypox infection has gone from being an endemic infection to a worldwide health emergency.</span></p></div><div><h3>Case summary</h3><p>In this article we present five cases of monkeypox earring infection of the pinna and what common features we have seen that differentiate them from <em>Staphylococcus aureus</em> infection.</p></div><div><h3>Discussion</h3><p><span>Symptoms of monkeypox include general malaise, fever with uni- or bilateral lymphadenopathy<span>, and then the appearance within one or two days of skin lesions, we want to alert he otolaryngologist and the medical society to the possibility the diagnostic possibility of monkeypox </span></span>in patients with an auricular perichondritis.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 129-132"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号